Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
0.27 → 0.27 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for SWMR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve gross margin target | The company aims for a gross margin of 80%. | Improving | Gross margin falls below 70% | Gross margin: 84.84% FY2026-Q2; GAAP. Published target: >=80%. Target period is not explicitly aligned with this observation. Aug 14, 202684.836401 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 10, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business with significant losses, rather than a proven compounder. The long-term thesis is on watch: revenue growth is strong, but recent performance trails its industry cohort and profitability has worsened.
SWMR is valued at a substantial premium to peers, with the valuation case resting on future opportunity, or optionality. Model confidence is low, and the evidence does not show that the market has priced in a broader stack of weakness and turbulence.
Near term, revenue growth from strategic agreements and licensing is a clear positive, but operating losses and net losses have widened despite management's focus on improving them. The next-quarter earnings miss risk is elevated, and leadership stability remains a watch item amid the CEO transition.
Over the next 1 to 3 years, the thesis depends on whether agreements and licensing can sustain growth while losses narrow. In the near term, rate cuts or steadier results from major technology companies could support the sector backdrop; materially slower GDP growth could weigh on growth-sensitive technology businesses.
SWMR has a strong growth signal but an unproven path to better profitability, alongside an expensive peer valuation and low evidence confidence. The multi-year view remains on watch until execution and earnings progress provide clearer support. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Swarmer, Inc.'s published investment case. The stated target is >= -$5M. |
| Broken |
| Operating income remains worse than -$7M |
Operating income: $-7.28M FY2026-Q2; GAAP. Published target: >= -$5M. Target period is not explicitly aligned with this observation. Aug 14, 2026-7,279,573 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth through strategic agreements | Swarmer is expanding its market presence through strategic partnerships. | Intact | Revenue growth falls below 100% YoY | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.27 → $0.27 · observed estimates
$0.03B → $0.03B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-08-27 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-08-28 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-08-29 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-08-30 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-08-31 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-01 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-02 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-03 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-04 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-05 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-06 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-07 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-08 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-09 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-10 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-11 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-12 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-13 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-14 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-15 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-16 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-17 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-18 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-19 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-20 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-21 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-22 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-23 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-24 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-25 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-26 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-27 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-28 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-29 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-09-30 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-01 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-02 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-03 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-04 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-05 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-06 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-07 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-08 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-09 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-10 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-11 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-12 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-13 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-14 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-15 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-16 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-17 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-18 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-19 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-20 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-21 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-22 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-23 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-24 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-25 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-26 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-27 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-28 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-29 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-30 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-10-31 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-11-01 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-11-02 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-11-03 | $0.27 | $25,010,000 | 1 / 1 |
| 2026-11-04 | $0.27 | $25,010,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.